Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Primary Purpose : Treatment
Allocation : Randomized
Interventional Model : Parallel Assignment
Masking : Double (ParticipantInvestigator)
Primary outcome measures:
Percentage of Participants With Clinically Relevant Hemolysis, Percentage of Female Participants With Moderate Glucose-6 Phosphate Dehydrogenase (G6PD) Deficiency Experiencing Clinically Relevant Hemolysis.
The decline in hemoglobin levels among patients with normal glucose-6-phosphate dehydrogenase (G6PD) enzyme activity was similar for both tafenoquine and primaquine. Tafenoquine was effective in the radical cure of P. vivax malaria, but it was not proven to be…